Truvada and other antiretroviral drugs containing the active ingredient tenofovir disproxil increase the risk of bone density loss, fracture, renal impairment, and kidney failure. Among the most popular HIV drugs in the world, Truvada has serious side effects that cause injury and permanent damage to persons already suffering from HIV. A safer version of tenofovir, known as TAF, is an effective antiretroviral that does not pose the same risk for kidney problems and bone density loss.
Despite early indications that TAF was a safer alternative with lower toxicity, the drugmaker halted clinical research for several years, resuming only when its patent on Truvada was set to expire. Truvada earned more than $11 billion annually at its height for Gilead Sciences, Inc. Critics says the company purposefully delayed TAF research in order to prolong its patent on tenofovir-containing drugs and safeguard its market dominance. Meanwhile, millions of HIV-positive Americans were exposed to a heightened risk for serious and permanent injuries including kidney failure, renal impairment, bone density loss, and bone fractures. Gilead received FDA Truvada warning letters on two occasions when drug company representatives were caught downplaying Truvada side effects and making false claims about the drug's safety.
Now Gilead Sciences, Inc. faces serious questions regarding the timeline of its development of TAF. Persons and the family members of persons who suffered from side effects such as broken and brittle bones, osteoporosis, and kidney failure after taking antiretrovirals including Truvada, Viread, Stribild, Atripla, Symfi Lo, AccessPak for HIV PEP Expanded with Kaletra, AccessPak for HIV PEP Expanded with Viracept, Complera, Cimduo, or Genvoya are filing bone and kidney failure lawsuits against Gilead. Filing a Truvada lawsuit is the only means individuals and families have to obtain the compensation they deserve for suffering, damage, medical expenses and loss related to Truvada kidney failure or osteoporosis. In addition, filing a Truvada lawsuit claim is the best method for individual consumers to hold Gilead accountable for its unethical business practices.
Persons and family members of persons who have suffered from Truvada side effects such as osteoporosis, kidney failure, and broken or brittle bones may be entitled to compensation through filing Truvada lawsuits. Individuals who match this description are eligible for free, no-obligation case reviews with an attorney handling national Truvada problems lawsuit claims. Truvada lawsuits against the drugmaker, Gilead, are the most effective means for consumers to recover compensation and hold the company accountable for the harm Truvada has caused. Lawyers handling Truvada lawsuits for kidney and bone problems work on contingency, meaning you will never pay legal fees unless we win compensation for you. Read full Truvada lawsuit
information from attorneys handling broken bone and kidney disease claims claims from plaintiffs nationwide.
Our Truvada attorneys have a long track record of success against billion dollar pharmaceutical corporations, winning compensation for individuals and families harmed by corporate negligence and greed. When a multinational pharmaceutical corporation appears to be profiting at the expense of consumer safety, our Truvada lawyer group sees it as our mission to pursue justice no matter how complex the case. Our attorneys handling kidney and bone cases related to Truvada, Viread, Stribild, Atripla, Symfi Lo, AccessPak for HIV PEP Expanded with Kaletra, AccessPak for HIV PEP Expanded with Viracept, Complera, Cimduo, or Genvoya help individuals recover the compensation they need and deserve, while holding companies accountable for wrongdoing and harm. Read full information from Truvada attorneys
for filing a claim against Gilead.
Studies show that persons who have taken any one of several antiretroviral drugs for HIV are at risk for osteoporosis, brittle bones, and bone fractures. Truvada bone problems are the result of decreased bone mineral density. Bone mineral density naturally diminishes throughout life, but persons taking certain tenofovir drugs including Truvada, Viread, Stribild, Atripla, Symfi Lo, AccessPak for HIV PEP Expanded with Kaletra, AccessPak for HIV PEP Expanded with Viracept, Complera, Cimduo, and Genvoya are more prone to osteoporosis and broken bones. Persons and family members of persons who have suffered from brittle or broken bones as a result of taking TDF may be eligible for compensation through filing a Truvada bone fracture lawsuit against Gilead. Read full Truvada osteoporosis and bone toxicity
Research indicates that the risk of kidney problems and renal failure increases among HIV positive patients taking TDF antiretrovirals including Truvada, Viread, Stribild, Atripla, Symfi Lo, AccessPak for HIV PEP Expanded with Kaletra, AccessPak for HIV PEP Expanded with Viracept, Complera, Cimduo, and Genvoya. A newer version of the drug, TAF, does not result in the same degree of Truvada kidney failure, yet the company purposefully delayed release of the drug to prolong its patent. Persons and family members of persons who have experienced kidney failure after taking a tenofovir medication may be eligible for compensation through filing a Truvada renal failure lawsuit against Gilead. Read full
Truvada kidney failure